Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1177 (LINC01177) is a human gene encoding a long intergenic non-coding RNA (lincRNA) molecule, which means it produces an RNA transcript longer than 200 nucleotides that does not overlap with annotated protein-coding genes or appear to encode a protein product[1][5]. The broader class of lincRNAs, to which LINC01177 belongs, is recognized for regulatory functions at the chromatin and transcriptional levels, including modulation of gene expression, chromatin remodeling, and stabilization of RNA[3][7]. lincRNAs may also have tissue-specific regulation and enhancer-like functions. Some (but not all) lincRNAs have been experimentally linked to roles in gene regulation, development, or disease, but as of current databases and publications, there are no specific documented functions, pathobiological roles, disease associations, drug interactions, or biomarker utility identified specifically for LINC01177[1][5]. The functional landscape of lincRNAs continues to emerge, with only a fraction functionally characterized; LINC01177 is currently annotated as a lincRNA with no further characterization available in the cited literature[1][5]. Notes on ambiguity and limitations: - While lincRNAs as a group are biologically important and implicated in gene regulation and disease, LINC01177 does not appear in public resources or the current literature as a disease target, biomarker, or therapeutic target. - No mis-spellings, naming conflicts, or incorrect associations were detected for LINC01177 in the referenced genomic and scientific databases. - No information exists regarding drugs, patient biomarkers, or safety concerns for this lincRNA at this time[1][5]. Summary: LINC01177 is a long intergenic non-coding RNA gene described in human genomics resources. It falls under the "Other" molecular classification as a lincRNA, without evidence supporting its classification as a therapeutic target, disease gene, or biomarker to date[1][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1177 (LINC01177).